|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Advances to Suppliers | ||||||||||||||||||||
| Receivable from Citi Bank | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Right of use asset – operating lease – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total right of use asset – operating lease – related party | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Notes payable – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes payable – related party | ||||||||||||||||||||
| Loan payable – related party | ||||||||||||||||||||
| Accrued royalty– related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accrued royalty– related party | ||||||||||||||||||||
| Interest on Related Party Loan | ||||||||||||||||||||
| Operating lease obligation, current portion – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total operating lease obligation, current portion – related party | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-Current Liabilities: | ||||||||||||||||||||
| Notes payable – related party | ||||||||||||||||||||
| Right of Use Liabilities | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total right of Use Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Deficit: | ||||||||||||||||||||
| Common stock, par value $0.001 per share; 1,100,000,000 shares authorized; 102,500,000 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated Deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
